Citations

Clear

426 citation(s) found for "ST, Reza".

Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients—A Tale of Two Cities
Mannan, Rahul , Zhang, Yuping , Chinnaiyan, Anya, Rangaswamy, Roshni, Chugh, Seema , Cao, Xuhong , Hafez, Khaled S., Vaishampayan, Ulka N. , McKenney, Jesse K. , Gupta, Sounak , Tretiakova, Maria , Argani, Pedram , Mehra, Rohit , Vaishampayan, Ulka , Tretiakova, Maria S , Wang, Xiaoming , Su, Fengyun , Wang, Rui , Skala, Stephanie L. , Picken, Maria M. , Alaghehbandan, Reza , Chinnaiyan, Arul , Dhanasekaran, Saravana Mohan

Mayo Clinic

American Journal of Surgical Pathology | November 23, 2023 | Volume: 48 | Issue: 2 | Pages: 163-173

10.1097/pas.0000000000002152 | PMID 37994665 Get It

Birt-Hogg-Dubé (BHD) syndrome is associated with an increased risk of multifocal renal tumors, including hybrid oncocytic tumor (HOT) and chromophobe renal cell carcinoma (chRCC). HOT exhibits heterogenous histologic features overlapping with chRCC and benign renal oncocytoma, posing challenges in diagnosis of HOT and renal tumor entities resembling HOT. In this study, we performed integrative analysis of bulk and single-cell RNA sequencing data from renal tumors and normal kidney tissues, and nominated candidate biomarkers of HOT, L1CAM, and LINC01187, which are also lineage-specific markers labeling the principal cell and intercalated cell lineages of the distal nephron, respectively. Our findings indicate the principal cell lineage marker L1CAM and intercalated cell lineage marker LINC01187 to be expressed mutually exclusively in a unique checkered pattern in BHD-associated HOTs, and these 2 lineage markers collectively capture the 2 distinct tumor epithelial populations seen to co-exist morphologically in HOTs. We further confirmed that the unique checkered expression pattern of L1CAM and LINC01187 distinguished HOT from chRCC, renal oncocytoma, and other major and rare renal cell carcinoma subtypes. We also characterized the histopathologic features and immunophenotypic features of oncocytosis in the background kidney of patients with BHD, as well as the intertumor and intratumor heterogeneity seen within HOT. We suggest that L1CAM and LINC01187 can serve as stand-alone diagnostic markers or as a panel for the diagnosis of HOT. These lineage markers will inform future studies on the evolution and interaction between the 2 transcriptionally distinct tumor epithelial populations in such tumors.
Aortic Valve Calcium Score by Computed Tomography as an Adjunct to Echocardiographic Assessment—A Review of Clinical Utility and Applications
Scalia, Isabel G. , Farina, Juan M. , Padang, Ratnasari , Jokerst, Clinton, Pereyra, Milagros , Mahmoud, Ahmed , Naqvi, Tasneem Z. , Oh, Jae K. , Arsanjani, Reza , Arsanjani, Reza , Naqvi, Tasneem Z , Farina, Juan M , Pereyra, Milagros , Mahmoud, Ahmed K , Scalia, Isabel G , Chao, Chieh‐Ju

Mayo Clinic

Journal of Imaging | November 16, 2023 | Volume: 9 | Issue: 11 | Pages: 250

10.3390/jimaging9110250 | PMID 37998097 Get It

Aortic valve stenosis (AS) is increasing in prevalence due to the aging population, and severe AS is associated with significant morbidity and mortality. Echocardiography remains the mainstay for the initial detection and diagnosis of AS, as well as for grading of severity. However, there are important subgroups of patients, for example, patients with low-flow low-gradient or paradoxical low-gradient AS, where quantification of severity of AS is challenging by echocardiography and underestimation of severity may delay appropriate management and impart a worse prognosis. Aortic valve calcium score by computed tomography has emerged as a useful clinical diagnostic test that is complimentary to echocardiography, particularly in cases where there may be conflicting data or clinical uncertainty about the degree of AS. In these situations, aortic valve calcium scoring may help re-stratify grading of severity and, therefore, further direct clinical management. This review presents the evolution of aortic valve calcium score by computed tomography, its diagnostic and prognostic value, as well as its utility in clinical care.
Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the GBD Study 2019
Aminorroaya, Arya , Moghaddam, Sahar Saeedi , Heidari, Behnam , Ebrahimi, Hedyeh , Naderian, Mohammadreza , Shobeiri, Parnian , Ghanbari, Ali , Rezaei, Nazila , Haghshenas, Rosa , Rezaei, Negar , Farzadfar, Farshad , Saeedi Moghaddam, Sahar , Tavolinejad, Hamed , Ebrahimi, Hedyeh , Naderian, Mohammadreza , Shobeiri, Parnian , Rezaei, Nazila , Malekpour, Mohammad-Reza , Haghshenas, Rosa , Rezaei, Negar , Larijani, Bagher , Farzadfar, Farshad , Aryan, Zahra , Malekpour, Mohammad‐Reza , Larijani, Bagher

Mayo Clinic

Journal of the American Heart Association | November 13, 2023 | Volume: 13 | Issue: 2 | Pages: No page available

10.1161/jaha.123.030165 | PMID 37956220 Get It

Background The North Africa and Middle East (NAME) region has one of the highest burdens of ischemic heart disease (IHD) worldwide. This study reports the contemporary epidemiology of IHD in NAME. Methods and Results We estimated the incidence, prevalence, deaths, years of life lost, years lived with disability, disability‐adjusted life years (DALYs), and premature mortality of IHD, and its attributable risk factors in NAME from 1990 to 2019 using the results of the GBD (Global Burden of Disease study 2019). In 2019, 0.8 million lives and 18.0 million DALYs were lost due to IHD in NAME. From 1990 to 2019, the age‐standardized DALY rate of IHD significantly decreased by 33.3%, mostly due to the reduction of years of life lost rather than years lived with disability. In 2019, the proportion of premature death attributable to IHD was higher in NAME compared with global measures: 26.8% versus 16.9% for women and 18.4% versus 14.8% for men, respectively. The age‐standardized DALY rate of IHD attributed to metabolic risks, behavioral risks, and environmental/occupational risks significantly decreased by 28.7%, 37.8%, and 36.4%, respectively. Dietary risk factors, high systolic blood pressure, and high low‐density lipoprotein cholesterol were the top 3 risks contributing to the IHD burden in most countries of NAME in 2019. Conclusions In 2019, IHD was the leading cause of death and lost DALYs in NAME, where premature death due to IHD was greater than the global average. Despite the great reduction in the age‐standardized DALYs of IHD in NAME from 1990 to 2019, this region still had the second‐highest burden of IHD in 2019 globally.
The role of serum lipoprotein(a) levels in bioprosthetic aortic valve degeneration
Fariña, Juliana, Roarke, M., Barry, Timothy, Sweeney, John P., Fortuin, David, Lester, Steven J., Oh, Jae K. , Marcotte, F, Pereyra, Milagros , Pereyra, Milagros , Farina, J, Chao, Chieh‐Ju , Said, E, Alsidawi, Said , Sell‐Dottin, Kristen , Ayoub, C, Arsanjani, Reza

Mayo Clinic

European Heart Journal | November 11, 2023 | Volume: 44 | Issue: Supplement_2 | Pages: No page available

10.1093/eurheartj/ehad655.1616 Get It

Abstract Introduction Lipoprotein(a) [Lp(a)] is associated with an increased incidence of aortic stenosis. Bioprosthetic aortic valve degeneration and native aortic stenosis share similar pathological mechanisms. Evidence regarding the role of serum Lp(a) concentrations in bioprosthetic aortic valve degeneration is lacking. Purpose To evaluate the association between serum Lp(a) concentrations and bioprosthetic aortic valve degeneration. Methods In this retrospective multicenter study, consecutive patients who underwent a bioprosthetic aortic valve replacement between Jan-2010 and Dec-2020 and had a preoperatory serum Lp(a) measurement were included. A baseline transthoracic echocardiography (TTE) was performed following the aortic valve replacement and a follow-up TTE was performed at least 24 months after the baseline study to determine the presence of bioprosthetic valve degeneration. Significant degeneration was defined as: (a) an increase >10 mmHg in mean bioprosthetic aortic valve gradient from baseline status + a decrease in effective orifice area + a decrease in Doppler velocity index + exclusion of clinically thrombotic leaflet thickening, OR (b) new moderate or severe prosthetic aortic regurgitation (if the main component was periprosthetic, then it was not considered). Lp(a) concentrations were compared between patients with and without degeneration and regression analysis was conducted to investigate the association between bioprosthetic valve degeneration and Lp(a) levels. Results In total, 211 cases were included (mean age 74.1 ±9.4 years, 72.0% males, 29.9% transcatheter aortic valve replacements) (Figure 1). Median time between baseline and follow-up TTE was 5.0 (IQR 3.7) years. Bioprostheses degeneration was observed in 33 (15.6%) patients at follow-up. Median serum levels of Lp(a) were significantly higher in the patients affected by degeneration versus non-affected cases (50.0 vs 15.7 mg/dl, p=0.003). In the regression analysis, high Lp(a) levels (≥30 mg/dl) were associated with degeneration both in a univariate analysis (OR 4.8, 95%CI 2.2-10.9, p<0.001) and multivariate analysis adjusted by other risk factors for bioprostheses degeneration (age, sex, hypertension, smoking, patient prosthesis mismatch, creatinine levels, and body surface area) (OR 5.2, 95%CI 2.1-12.8, p<0.001). Conclusion Serum Lp(a) concentrations seem to be a risk factor for bioprosthetic aortic valve degeneration (Figure 2). There is an increasing need to accurately predict bioprosthetic aortic valve degeneration and to develop novel methods and treatments to increase their durability. Prospective studies are needed to confirm these findings and to investigate whether lowering Lp(a) could slow bioprostheses degradation.Population characteristicsLp(a) and bioprostheses degeneration
Decoding breast cancer Histopathology: Machine Learning-Enhanced Advanced Mathematical Models in Multi-B-Value MR Diffusion Imaging
Amini, Behnam, Ghasemi, Moein , Farazandeh, Dorreh, Farzaneh, Hana, Torabi, Sarah, Sedaghat, Mona, Jafarimehrabady, Niloofar, Hajiabbasi, Mobasher , Aziz, Ashkan, Gorjestani, OmidReza, Naviafar, Anahita, Alaei, Maryam , Karimi, Nastaran, Parsaei, Amirhossein , Doshmanziari, Reza, Vajihinejad, Maryam , Rikhtehgar, Masih , Nokiani, Alireza Almasi, Torabi, Sarah, Gorjestani, OmidReza, Hosseini, Mohammad M., Doshmanziari, Reza, Dehnavi, Ali Zare , Nokiani, Alireza Almasi

Mayo Clinic

No container title available | November 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3520062/v1 Get It

Abstract This study aims to advance breast cancer (BC) subtype classification by employing machine learning algorithms to identify key diffusion parameters from apparent diffusion coefficient (ADC0-800) histogram, intravoxel incoherent motion (IVIM), and diffusion kurtosis imaging (DKI). A total of 148 newly diagnosed BC patients were enrolled, confirmed through core needle biopsy, and subjected to histopathological analyses to assess key molecular markers such as estrogen and progesterone receptors (collectively termed hormone receptors), HER2, and ki67. These markers were then used to classify BC subtypes. Utilizing advanced post-processing techniques on multi-b-value MR Images, the study employed a diverse set of machine learning (ML) algorithms (supervised, unsupervised, and deep learning techniques) to quantitatively assess their diagnostic utility and subsequently identify algorithmically refined diffusion signatures. Machine learning algorithms demonstrated varying efficacies in the classification of BC subtypes. Key diffusion parameters were prioritized based on feature importance values from the ML models with the highest mean AUC and were further validated using group comparison tests and univariate logistic regression. In conclusion, our findings underscore the importance of tailored ML algorithms in classifying BC subtypes and advocate for a synergistic approach in personalized oncology and precision medicine.
Artificial Intelligence-Based Prediction of Cardiovascular Diseases from Chest Radiography
Farina, Juan M. , Pereyra, Milagros , Mahmoud, Ahmed , Scalia, Isabel G. , Abbas, Mohammed Tiseer , Barry, Timothy , Ayoub, Chadi , Banerjee, Imon , Arsanjani, Reza , Barry, Timothy , Arsanjani, Reza , Banerjee, Imon , Farina, Juan M , Pereyra, Milagros , Mahmoud, Ahmed K , Scalia, Isabel G , Abbas, Mohammed Tiseer , Chao, Chieh‐Ju

Mayo Clinic

Journal of Imaging | October 27, 2023 | Volume: 9 | Issue: 11 | Pages: 236

10.3390/jimaging9110236 | PMID 37998083 Get It

Chest radiography (CXR) is the most frequently performed radiological test worldwide because of its wide availability, non-invasive nature, and low cost. The ability of CXR to diagnose cardiovascular diseases, give insight into cardiac function, and predict cardiovascular events is often underutilized, not clearly understood, and affected by inter- and intra-observer variability. Therefore, more sophisticated tests are generally needed to assess cardiovascular diseases. Considering the sustained increase in the incidence of cardiovascular diseases, it is critical to find accessible, fast, and reproducible tests to help diagnose these frequent conditions. The expanded focus on the application of artificial intelligence (AI) with respect to diagnostic cardiovascular imaging has also been applied to CXR, with several publications suggesting that AI models can be trained to detect cardiovascular conditions by identifying features in the CXR. Multiple models have been developed to predict mortality, cardiovascular morphology and function, coronary artery disease, valvular heart diseases, aortic diseases, arrhythmias, pulmonary hypertension, and heart failure. The available evidence demonstrates that the use of AI-based tools applied to CXR for the diagnosis of cardiovascular conditions and prognostication has the potential to transform clinical care. AI-analyzed CXRs could be utilized in the future as a complimentary, easy-to-apply technology to improve diagnosis and risk stratification for cardiovascular diseases. Such advances will likely help better target more advanced investigations, which may reduce the burden of testing in some cases, as well as better identify higher-risk patients who would benefit from earlier, dedicated, and comprehensive cardiovascular evaluation.
Left ventricle outflow tract obstruction after transcatheter mitral valve replacement with a transatrial approach
Farina, Juan M. , Jokerst, Clinton, Wilansky, Susan , Arsanjani, Reza , Arsanjani, Reza , Farina, Juan M , Sell‐Dottin, Kristen

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | October 23, 2023 | Volume: 25 | Issue: 3 | Pages: e108-e108

10.1093/ehjci/jead279 | PMID 37875138 Get It

Impact of hypertriglyceridaemia on cardiovascular mortality according to low-density lipoprotein cholesterol in a 15.6-million population
Hong, Sung‐Jin , Yi, Sang‐Wook , Yi, Sang-Wook , Park, Hyung‐Bok , Arsanjani, Reza , Yi, Jee‐Jeon

Mayo Clinic

European Journal of Preventive Cardiology | October 16, 2023 | Volume: 31 | Issue: 3 | Pages: 280-290

10.1093/eurjpc/zwad330 | PMID 37850354 Get It

Abstract Aims The aim of this study was to assess the association between triglyceride (TG) levels and cardiovascular disease (CVD) mortality concerning low-density lipoprotein cholesterol (LDL-C) and age in the general population. Methods and results From the Korean National Health Insurance Service database, 15 672 028 participants aged 18–99 who underwent routine health examinations were followed up for CVD mortality. Hazard ratios for CVD mortality were calculated using Cox models after adjusting for various confounders. During a mean of 8.8 years of follow-up, 105 174 individuals died of CVD. There was a clear log-linear association between TG and overall CVD mortality down to 50 mg/dL. Each two-fold increase in TG was associated with 1.10-fold (overall CVD), 1.22-fold [ischaemic heart disease (IHD)], 1.24-fold [acute myocardial infarction (AMI)], and 1.10-fold (ischaemic stroke) higher CVD mortality. Haemorrhagic stroke and heart failure were not associated with TG levels. The impact of hypertriglyceridaemia (HTG) on CVD weakened but remained present in persons with LDL-C < 100 mg/dL, in whom each two-fold higher TG was associated with 1.05-fold (overall CVD), 1.12-fold (IHD), 1.15-fold (AMI), and 1.05-fold (ischaemic stroke) higher CVD mortality. The younger population (18–44 years) had stronger associations between TG levels and mortality from overall CVD, IHD, and AMI than the older population. Conclusion Hypertriglyceridaemia independently raises CVD mortality with lingering risks in young and older individuals with low LDL-C levels, suggesting the importance of management of HTG even with controlled LDL-C.
Percutaneous transcatheter pulmonary and tricuspid valve replacements in a patient with carcinoid heart disease
Pereyra, Milagros , Arsanjani, Reza , Arsanjani, Reza , Pereyra, Milagros , Farina, Juan M. , Chao, Chieh‐Ju

Mayo Clinic

European Heart Journal - Case Reports | October 13, 2023 | Volume: 7 | Issue: 11 | Pages: No page available

10.1093/ehjcr/ytad511 | PMID 38025127 Get It

Challenges and solutions of echocardiography generalization for deep learning: a study in patients with constrictive pericarditis
Jeong, Jiwoong , Pelkey, Melissa N. , Chen, Yi‐Chieh , Ramzan, Raheel N., Elbahnasawy, Mohammad , Sleem, Mohamed, Grogan, Martha , Kane, Garvan C. , Patel, Bhavik N. , Oh, Jae K. , Banerjee, Imon , Chao, Chieh-Ju , Arsanjani, Reza , Kim, Kihong, Pelkey, Melissa N , Chen, Yi-Chieh , Farina, Juan Maria M, Banerjee, Imon , Chao, Chieh‐Ju , Arsanjani, Reza , Kim, Kihong , Farina, Juan M.

Mayo Clinic

Journal of Medical Imaging | October 12, 2023 | Volume: 10 | Issue: 05 | Pages: No page available

10.1117/1.jmi.10.5.054502 | PMID 37840850 Get It